Hemoglobin, Lactate Dehydrogenase, and FACIT-Fatigue Normalization in Pegcetacoplan-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria from Two Phase 3 Clinical Trials

被引：0
|
作者：
Desai, Dharmik [1 ]
Mulherin, Brian P. [2 ,3 ]
Yeh, Michael [1 ]
Al-Adhami, Mohammed [1 ]
Savage, Jessica [1 ]
Dingli, David [4 ]
机构：
[1] Apellis Pharmaceut Inc, Waltham, MA USA
[2] Hematol Oncol Indiana, Indianapolis, IN USA
[3] Ascension St Vincent Carmel, Carmel, CA USA
[4] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
MDS; paroxysmal nocturnal hemoglobinuria; PNH; pegcetacoplan; normalization; hemoglobin; complement-inhibitor; Phase III;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDS-111
引用
收藏
页码：S304 / S304
页数：1
相关论文
共 47 条
  • [1] Hemoglobin, Lactate Dehydrogenase, and FACIT-Fatigue Normalization in Pegcetacoplan-treated Patients with Paroxysmal Nocturnal Hemoglobinuria
    Tapia, Jose
    Mulherin, Brian
    Yeh, Michael
    Al-Adhami, Mohammed
    Savage, Jessica
    Dingli, David
    [J]. ANESTHESIA AND ANALGESIA, 2022, 135 (3S_SUPPL): : 11 - 12
  • [2] Normalization of Hemoglobin, Lactate Dehydrogenase, and Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan
    Mulherin, Brian P.
    Yeh, Michael
    Al-Adhami, Mohammed
    Dingli, David
    [J]. DRUGS IN R&D, 2024, 24 (02) : 169 - 177
  • [3] Hemoglobin, lactate dehydrogenase, and facit-fatigue normalization rates in patients treated with pegcetacoplan: Results from the pegasus and prince phase 3 clinical trials
    Mulherin, B.
    Yeh, M.
    Al-Adhami, M.
    Savage, J.
    Dingli, D.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 246 - 247
  • [4] Pegcetacoplan treatment meaningfully improves quality of life and fatigue in patients with paroxysmal nocturnal hemoglobinuria: results from two phase 3 clinical trials
    Kubal, T.
    Mulherin, B.
    Yeh, M.
    Al-Adhami, M.
    Savage, J.
    Dingli, D.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 468 - 469
  • [5] Thrombosis and meningococcal infection rates in pegcetacoplan-treated patients with paroxysmal nocturnal hemoglobinuria in the clinical trial and postmarketing settings
    Kelly, Richard J.
    Nishimori, Hisakazu
    Horneff, Regina
    Hillmen, Peter
    Al-Adhami, Mohammed
    Lallier, Stacie
    Gerber, Gloria F.
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (04)
  • [6] Rapid Time to a Clinically Meaningful Response in FACIT-Fatigue Scores With Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Kaplan-Meier Analysis from the PEGASUS Trial
    Desai, Dharmik
    Fishman, Jesse
    Zhang, Xuan
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S306 - S306
  • [7] Rapid time to a two-level improvement in FACIT-Fatigue individual item scores with pegcetacoplan in adults with paroxysmal nocturnal hemoglobinuria: a Kaplan-Meier analysis from the PEGASUS trial
    Fishman, Jesse
    Zhang, Xuan
    [J]. QUALITY OF LIFE RESEARCH, 2022, 31 : S111 - S111
  • [8] Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Pegasus Phase 3 Trial Comparing Pegcetacoplan to Eculizumab
    Roth, Alexander
    Hoechsmann, Britta
    Griffin, Morag
    De Castro, Carlos M.
    Szer, Jeffrey
    Usuki, Kensuke
    Soret, Juliette
    Hamdani, Mohamed
    Ajayi, Temitayo
    Sarda, Sujata P.
    Panse, Jens
    [J]. BLOOD, 2020, 136
  • [9] C3 Inhibition with Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Paddock and Palomino Trials
    Wong, Raymond S.
    Ignatova, Kalina
    Pullon, Humphrey
    Sathar, Jameela
    Niparuck, Pimjai
    Numbenjapon, Tontanai
    Tse, Eric
    Issaragrisil, Surapol
    Roman, Eloy
    Amine, Ismail
    Tan, Lisa
    Di Casoli, Carl
    Deschatelets, Pascal
    Francois, Cedric
    Grossi, Federico
    Bogdanovic, Andrija
    [J]. BLOOD, 2020, 136
  • [10] C3 Inhibition with pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria: results from the Paddock and Palomino trials
    Wong, Raymond
    Ignatova, Kalina
    Pullon, Humphrey
    Sathar, Jameela
    Niparuck, Pimjai
    Numbenjapon, Tontanai
    Tse, Eric
    Issaragrisil, Surapol
    Roman, Eloy
    Amine, Ismail
    Tan, Lisa
    di Casoli, Carl
    Deschatelets, Pascal
    Francois, Cedric
    Grossi, Federico
    Bogdanovic, Andrija
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 187 - 188
12345